GILD : Insider Transactions for Gilead Sciences Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Gilead Sciences Inc (GILD)

$64.70

0.85 (1.33%) as of 4:30 Fri 6/7

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

1,250,000,000

Market Cap:

80.88(B)

Last Volume:

7,412,694

Avg Vol:

8,704,124

52 Week Range:

$63.43 - $87.29

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

	S&P COMPOSITE 1500		NASDAQ BIOTECHNOLOGY
	NASDAQ COMPOSITE		NASDAQ-100
	S&P 500		NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 259

Guru Rank Value : 4.6

Guru Occurances : 2


6 Months 1 Year 2 Year

Company Profile Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	2,000	25,472	38,458	80,792
Total Sell Value	$145,920	$2,022,270	$3,052,046	$6,445,296
Total People Sold	1	3	3	4
Total Sell Transactions	1	5	9	14
End Date	2024-03-10	2023-12-08	2023-06-09	2022-06-09

Adjust Filter Settings

Records found: 2499

Page 23 of 100

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

EVP Worldwide Commercial Ops

• • –

2017-11-09

4

A

$0.00

$0

D/D

2,700

5,415

-

Chief Operating Officer

• • –

2017-11-09

4

D

$73.02

$249,874

D/D

(3,422)

10,076

-

Chief Operating Officer

• • –

2017-11-09

4

A

$0.00

$0

D/D

6,810

13,498

-

EVP Worldwide Commercial Ops

• • –

2017-11-05

4

GA

$0.00

$0

I/I

2,288

128,433

-

EVP Worldwide Commercial Ops

• • –

2017-11-05

4

GD

$0.00

$0

D/D

2,288

2,715

-

EVP Worldwide Commercial Ops

• • –

2017-11-05

4

D

$73.46

$162,494

D/D

(2,212)

5,003

-

EVP Worldwide Commercial Ops

• • –

2017-11-05

4

OE

$0.00

$0

D/D

4,500

7,215

-

EVP Comm&Acs ALA, Corp&Med Aff

• • –

2017-11-01

4

AS

$74.74

$1,122,285

D/D

(15,000)

62,363

-

EVP Comm&Acs ALA, Corp&Med Aff

• • –

2017-11-01

4

OE

$24.91

$214,806

D/D

8,625

77,363

-

Executive Chairman

• • –

2017-11-01

4

AS

$75.08

$5,509,697

D/D

(73,333)

2,996,766

-

Executive Chairman

• • –

2017-11-01

4

OE

$21.58

$1,582,159

D/D

73,333

3,070,099

-

EVP Comm&Acs ALA, Corp&Med Aff

• • –

2017-10-02

4

AS

$81.84

$2,066,307

D/D

(25,000)

68,738

-

EVP Comm&Acs ALA, Corp&Med Aff

• • –

2017-10-02

4

OE

$24.91

$429,611

D/D

17,250

93,738

-

Executive Chairman

• • –

2017-10-02

4

AS

$81.82

$6,054,319

D/D

(73,333)

2,996,766

-

Executive Chairman

• • –

2017-10-02

4

OE

$21.58

$1,582,159

D/D

73,333

3,070,099

-

Washington Robin L

EVP, CFO

• • –

2017-09-07

4

AS

$85.00

$1,535,950

I/I

(18,070)

103,477

-

Washington Robin L

EVP, CFO

• • –

2017-09-07

4

AS

$85.00

$2,868,750

D/D

(33,750)

9,602

-

Washington Robin L

EVP, CFO

• • –

2017-09-07

4

OE

$24.30

$819,956

D/D

33,750

43,352

-

Executive Chairman

• • –

2017-09-01

4

AS

$83.03

$6,094,992

D/D

(73,333)

2,996,766

-

Executive Chairman

• • –

2017-09-01

4

OE

$21.58

$1,582,159

D/D

73,333

3,070,099

-

EVP Comm&Acs ALA, Corp&Med Aff

• • –

2017-09-01

4

AS

$82.96

$2,076,188

D/D

(25,000)

76,488

-

EVP Comm&Acs ALA, Corp&Med Aff

• • –

2017-09-01

4

OE

$24.91

$429,611

D/D

17,250

101,488

-

Executive Chairman

• • –

2017-08-31

4

GD

$0.00

$0

D/D

129,870

2,996,766

-

EVP Worldwide Commercial Ops

• • –

2017-08-31

4

S

$83.01

$4,991,290

D/D

(60,000)

2,715

-

EVP Worldwide Commercial Ops

• • –

2017-08-31

4

OE

$21.00

$1,260,000

D/D

60,000

62,715

-

2499 Records found	Previous 20 21 22 23 24 25 26 27 28 29 Next	Page 23 of 100

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.